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Can posthysterectomy cystoscopy be utilized as a
screening test for bladder cancer?
Kann die Zystoskopie nach Hysterektomie als Screeningtest für
Harnblasenkrebs verwendet werden?
Abstract
It is currently undisputed that cystoscopy is required after each hyster-
ectomy to confirm the integrity of the urinary tract before leaving the
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operatingroom.Sometimes,secondaryfindingsaredetectedoncystos-
copy like interstitial cystitis and exophytic tumors. We are reporting a
case of asymptomatic bladder cancer discovered incidentally during a 1 Medical Center of Central
Georgia, Macon, GA, USA posthysterectomycystoscopy.Thechanceofawomanhavingthiscancer
is about 1 in 85. This demonstrates the additional merit of performing
cystoscopy after hysterectomy as a screening test for bladder cancer.
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Zusammenfassung
Es ist derzeit unbestritten, dass nach jeder Hysterektomie eine Zysto-
skopie erforderlich ist, um die Integrität des Harntrakts zu überprüfen,
bevor der Patient den Operationsraum verlässt. Bisweilen werden bei
der Zystoskopie zusätzliche Befunde erhoben, wie z. B. interstitielle
Zystitis oder ein oberflächlicher Tumor der Harnblase. Wir berichten
über einen Fall von asymptomatischem Harnblasenkrebs, der zufällig
bei einer Zystoskopie nach Hysterektomie entdeckt worden ist. Die
Häufigkeit von Blasenkrebs beträgt bei Frauen 1:85. Dieser Befund
demonstriertdenzusätzlichenNutzeneinerZystoskopienachHysterek-
tomie als einen Screeningtest für Blasenkrebs.
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Case presentation
Hysterectomyisthesecondmostfrequentmajorsurgical
procedure among reproductive age women with approxi-
mately 600,000 hysterectomies performed annually in
the United States [1]. It is currently undisputed that cys-
toscopy is required after each hysterectomy to confirm
theintegrityoftheurinarytractbeforeleavingtheoperat-
ing room [2]. Unrecognized injuries to the bladder or
ureters are unacceptable and lead to serious complica-
tions. Sometimes, secondary findings are detected on
cystoscopy like interstitial cystitis and exophytic tumors.
We are reporting a case of asymptomaticbladdercancer
discovered incidentally during a posthysterectomy cysto-
scopy.
A 42 year old patient, gravida 0, with a known fibroid
uterus and history of menometrorrhagia is admitted for
definitivesurgicaltreatment.Theuterusis14weekssize.
Her endometrial biopsy shows mild endometrial hyper-
plasiaandherPapsmeariswithinnormallimits.Informed
consent is obtained to proceed with total laparoscopic
hysterectomy.So,laparoscopichysterectomyisperformed
with uterine morcellation and as routinely done at the
endoftheoperationcystoscopyisperformed.Thisreveals
an exophytic bladder tumor above the ureteral orifice on
the right side (Figure 1A). Biopsies are taken with three
passes of a cup biopsy forceps and sent for pathology.
The bleeding site is fulgurated with point cautery using
the 20/20 cautery setting which gives good hemostasis
with no evidence of bladder injury (Figure 1B). Pathology
report comes with the diagnosis “papillary transitional
cell carcinoma, histologic grade I with no evidence of in-
vasion.” The specimen labeled “Uterus and Cervix”
weighed 520 grams and was negative for malignancy.
Because the bladder is the final storage cistern for ex-
creted toxins, there are many risk factors for bladder
cancer including smoking, occupational exposures,
drinking water with arsenic contamination, chemo- and
radiotherapy and chronic cystitis. The American Cancer
Society estimates that 68,810 new cases of bladder
cancerwillbediagnosedintheUnitedStatesduring2008
of which 14,100 people will die of the disease [3]. The
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Case Report OPEN ACCESSFigure 1: A: An exophytic tumor in the bladder discovered incidentally during posthysterectomy cystoscopy.
B: The bleeding site after biopsy.
chance of a woman having this cancer is about 1 in 85
[3]. For men, it is 1 in 27 [3].
Fortunately, most people with bladder cancer will not die
of the disease. Upon diagnosis, most patients have their
cancer confined to the bladder (74%). In 19% of the
cases, the cancer has invaded nearby tissues and in 3%
of cases there are metastases [3]. Earlier diagnosis is
important in reducing mortality. Females, however, are
approximately twice as likely as males to die from the
disease because of delay in diagnosis [4].
A conscientious gynecologist should not be timid about
biopsying bladder abnormalities detected at the time of
postoperative cystoscopy. Superficial mucosal biopsies
of papillary lesions will not bleed significantly and can
yieldimportantdiagnosticinformation.Itiseasiertotreat
bladder cancer if it is caught early. At this point, a routine
effective bladder cancer screening test has not yet been
established.Thereisinsufficientevidencethatadecrease
in mortality from bladder cancer occurs with hematuria
or urinary cytology testing [5]. This case illustrates the
additional merit of performing posthysterectomy cystos-
copy as a screening test for bladder cancer.
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